bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.11.28.625854

More or less latent variables in the high-dimensional data space? That is the question

Abstract

Dimensionality reduction is widely used in modern Neuro-science to process massive neural recordings data. Despite the development of complex non-linear techniques, linear algorithms, in particular Principal Component Analysis (PCA), are still the gold standard. However, there is no consensus on how to estimate the optimal number of latent variables to retain. In this study, we addressed this issue by testing different criteria on simulated data. Parallel analysis and cross validation proved to be the best methods, being largely unaffected by the number of units and the amount of noise. Parallel analysis was quite conservative and tended to underestimate the number of dimensions especially in low-noise regimes, whereas in these conditions cross validation provided slightly better estimates. Both criteria consistently estimate the ground truth when 100+ units were available. As an exemplary application to real data, we estimated the dimensionality of the spiking activity in two macaque parietal areas during different phases of a delayed reaching task. We show that different criteria can lead to different trends in the estimated dimensionality. These apparently contrasting results are reconciled when the implicit definition of dimensionality underlying the different criteria is considered. Our findings suggest that the term dimensionality needs to be defined carefully and, more importantly, that the most robust criteria for choosing the number of dimensions should be adopted in future works. To help other researchers with the implementation of such an approach on their data, we provide a simple software package, and we present the results of our simulations through a simple Web based app to guide the choice of latent variables in a variety of new studies. Key pointsO_LIParallel analysis and cross-validation are the most effective criteria for principal components retention, with parallel analysis being slightly more conservative in low-noise conditions, but being more robust with larger noise. C_LIO_LIThe size of data matrix as well as the decay rate of the explained variance decreasing curve strongly limit the number of latent components that should be considered. C_LIO_LIWhen analyzing real spiking data, the estimated dimensionality depends dramatically on the criterion used, leading to apparently different results. However, these differences stem, in large part, from the implicit definitions of dimensionality underlying each criterion. C_LIO_LIThis study emphasizes the need for careful definition of dimensionality in population spiking activity and suggests the use of parallel analysis and cross-validation methods for future research. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vaccari, F. E., Diomedi, S., Bettazzi, E., Filippini, M., De Vitis, M., Hadjidimitrakis, K., Fattori, P.. 2024-11-28. More or less latent variables in the high-dimensional data space? That is the question. https://doi.org/10.1101/2024.11.28.625854

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗